Which has higher earnings & valuation, TELA or CVRX?

TELA Bio has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TELA Bio $80.81M 0.39 -$38.83M -$0.79 N/A CVRx $59.07M 2.63 -$53.31M -$2.02 N/A

Is TELA or CVRX more profitable?

TELA Bio has a net margin of -49.30% compared to CVRx's net margin of -89.14%. CVRx's return on equity of -120.76% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% CVRx -89.14% -120.76% -48.38%

Which has higher valuation and earnings, GUTS or TELA?

TELA Bio has higher revenue and earnings than Fractyl Health. TELA Bio is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Fractyl Health $90K 1,309.74 -$140.95M -$1.29 N/A TELA Bio $80.81M 0.39 -$38.83M -$0.79 N/A

Is GUTS or TELA more profitable?

Fractyl Health has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. TELA Bio's return on equity of -1,320.81% beat Fractyl Health's return on equity. Company Net Margins Return on Equity Return on Assets Fractyl Health N/A -4,053.15% -96.41% TELA Bio -49.30% -1,320.81% -55.83%

Is MBOT or TELA more profitable?

Microbot Medical has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. Microbot Medical's return on equity of -21.84% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets Microbot Medical N/A -21.84% -20.71% TELA Bio -49.30% -1,320.81% -55.83%

Which has preferable valuation and earnings, RCEL or TELA?

TELA Bio has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avita Medical $71.61M 1.71 -$48.59M -$1.57 N/A TELA Bio $80.81M 0.39 -$38.83M -$0.79 N/A

Is RCEL or TELA more profitable?

TELA Bio has a net margin of -49.30% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets Avita Medical -62.67% N/A -78.92% TELA Bio -49.30% -1,320.81% -55.83%

Do analysts recommend TELA or FONR?

TELA Bio presently has a consensus target price of $2.20, suggesting a potential upside of 211.79%. Given TELA Bio's stronger consensus rating and higher possible upside, equities analysts clearly believe TELA Bio is more favorable than Fonar. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TELA Bio 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Fonar 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation & earnings, TELA or FONR?

Fonar has higher revenue and earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Fonar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TELA Bio $80.81M 0.39 -$38.83M -$0.79 N/A Fonar $105.34M 1.12 $8.33M $1.00 19.09

Is TELA or FONR more profitable?

Fonar has a net margin of 6.35% compared to TELA Bio's net margin of -49.30%. Fonar's return on equity of 4.12% beat TELA Bio's return on equity. Company Net Margins Return on Equity Return on Assets TELA Bio -49.30% -1,320.81% -55.83% Fonar 6.35% 4.12% 3.07%

TELA Bio (TELA) Competitors

$0.71 -0.03 (-4.65%)

Closing price 06/26/2026 04:00 PM Eastern

Extended Trading

$0.70 0.00 (-0.65%)

As of 06/26/2026 06:38 PM Eastern

Compare

TELA vs. CVRX, GUTS, MBOT, RCEL, and FONR

Should you buy TELA Bio stock or one of its competitors? MarketBeat compares TELA Bio with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with TELA Bio include CVRx (CVRX), Fractyl Health (GUTS), Microbot Medical (MBOT), Avita Medical (RCEL), and Fonar (FONR). These companies are all part of the "medical equipment" industry.

How does TELA Bio compare to CVRx?

TELA Bio (NASDAQ:TELA) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk and dividends.

94.3% of TELA Bio shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 5.1% of TELA Bio shares are owned by company insiders. Comparatively, 13.9% of CVRx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

TELA Bio has a beta of 1.33, indicating that its stock price is 33% more volatile than the broader market. Comparatively, CVRx has a beta of 0.8, indicating that its stock price is 20% less volatile than the broader market.

TELA Bio has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.81M	0.39	-$38.83M	-$0.79	N/A
CVRx	$59.07M	2.63	-$53.31M	-$2.02	N/A

In the previous week, TELA Bio and TELA Bio both had 2 articles in the media. TELA Bio's average media sentiment score of 1.44 beat CVRx's score of 0.94 indicating that TELA Bio is being referred to more favorably in the media.

Company	Overall Sentiment
TELA Bio	Positive
CVRx	Positive

TELA Bio has a net margin of -49.30% compared to CVRx's net margin of -89.14%. CVRx's return on equity of -120.76% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
CVRx	-89.14%	-120.76%	-48.38%

TELA Bio presently has a consensus target price of $2.20, suggesting a potential upside of 211.79%. CVRx has a consensus target price of $11.50, suggesting a potential upside of 96.25%. Given TELA Bio's higher possible upside, analysts plainly believe TELA Bio is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	3.00

Summary

TELA Bio beats CVRx on 10 of the 16 factors compared between the two stocks.

How does TELA Bio compare to Fractyl Health?

Fractyl Health (NASDAQ:GUTS) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

Fractyl Health has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. TELA Bio's return on equity of -1,320.81% beat Fractyl Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fractyl Health	N/A	-4,053.15%	-96.41%
TELA Bio	-49.30%	-1,320.81%	-55.83%

Fractyl Health presently has a consensus target price of $5.40, suggesting a potential upside of 626.78%. TELA Bio has a consensus target price of $2.20, suggesting a potential upside of 211.79%. Given Fractyl Health's higher probable upside, research analysts clearly believe Fractyl Health is more favorable than TELA Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fractyl Health	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

94.3% of TELA Bio shares are owned by institutional investors. 8.5% of Fractyl Health shares are owned by insiders. Comparatively, 5.1% of TELA Bio shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

TELA Bio has higher revenue and earnings than Fractyl Health. TELA Bio is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fractyl Health	$90K	1,309.74	-$140.95M	-$1.29	N/A
TELA Bio	$80.81M	0.39	-$38.83M	-$0.79	N/A

In the previous week, TELA Bio had 1 more articles in the media than Fractyl Health. MarketBeat recorded 2 mentions for TELA Bio and 1 mentions for Fractyl Health. Fractyl Health's average media sentiment score of 1.87 beat TELA Bio's score of 1.44 indicating that Fractyl Health is being referred to more favorably in the media.

Company	Overall Sentiment
Fractyl Health	Very Positive
TELA Bio	Positive

Fractyl Health has a beta of 2.34, meaning that its stock price is 134% more volatile than the broader market. Comparatively, TELA Bio has a beta of 1.33, meaning that its stock price is 33% more volatile than the broader market.

Summary

Fractyl Health and TELA Bio tied by winning 7 of the 14 factors compared between the two stocks.

How does TELA Bio compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

Microbot Medical has higher earnings, but lower revenue than TELA Bio. Microbot Medical is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	$105K	1,135.41	-$13.14M	-$0.26	N/A
TELA Bio	$80.81M	0.39	-$38.83M	-$0.79	N/A

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 94.3% of TELA Bio shares are held by institutional investors. 4.7% of Microbot Medical shares are held by insiders. Comparatively, 5.1% of TELA Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Microbot Medical had 1 more articles in the media than TELA Bio. MarketBeat recorded 3 mentions for Microbot Medical and 2 mentions for TELA Bio. TELA Bio's average media sentiment score of 1.44 beat Microbot Medical's score of 0.62 indicating that TELA Bio is being referred to more favorably in the news media.

Company	Overall Sentiment
Microbot Medical	Positive
TELA Bio	Positive

Microbot Medical presently has a consensus price target of $6.63, suggesting a potential upside of 273.24%. TELA Bio has a consensus price target of $2.20, suggesting a potential upside of 211.79%. Given Microbot Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe Microbot Medical is more favorable than TELA Bio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

Microbot Medical has a beta of 1.04, meaning that its share price is 4% more volatile than the broader market. Comparatively, TELA Bio has a beta of 1.33, meaning that its share price is 33% more volatile than the broader market.

Microbot Medical has a net margin of 0.00% compared to TELA Bio's net margin of -49.30%. Microbot Medical's return on equity of -21.84% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
TELA Bio	-49.30%	-1,320.81%	-55.83%

Summary

Microbot Medical beats TELA Bio on 10 of the 17 factors compared between the two stocks.

How does TELA Bio compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Avita Medical has a beta of 1.87, meaning that its stock price is 87% more volatile than the broader market. Comparatively, TELA Bio has a beta of 1.33, meaning that its stock price is 33% more volatile than the broader market.

TELA Bio has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$71.61M	1.71	-$48.59M	-$1.57	N/A
TELA Bio	$80.81M	0.39	-$38.83M	-$0.79	N/A

In the previous week, TELA Bio had 1 more articles in the media than Avita Medical. MarketBeat recorded 2 mentions for TELA Bio and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 1.87 beat TELA Bio's score of 1.44 indicating that Avita Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Avita Medical	Very Positive
TELA Bio	Positive

Avita Medical currently has a consensus target price of $7.25, indicating a potential upside of 82.62%. TELA Bio has a consensus target price of $2.20, indicating a potential upside of 211.79%. Given TELA Bio's stronger consensus rating and higher possible upside, analysts plainly believe TELA Bio is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

27.7% of Avita Medical shares are held by institutional investors. Comparatively, 94.3% of TELA Bio shares are held by institutional investors. 2.8% of Avita Medical shares are held by insiders. Comparatively, 5.1% of TELA Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

TELA Bio has a net margin of -49.30% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-62.67%	N/A	-78.92%
TELA Bio	-49.30%	-1,320.81%	-55.83%

Summary

TELA Bio beats Avita Medical on 11 of the 15 factors compared between the two stocks.

How does TELA Bio compare to Fonar?

TELA Bio (NASDAQ:TELA) and Fonar (NASDAQ:FONR) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

Fonar has higher revenue and earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than Fonar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TELA Bio	$80.81M	0.39	-$38.83M	-$0.79	N/A
Fonar	$105.34M	1.12	$8.33M	$1.00	19.09

Fonar has a net margin of 6.35% compared to TELA Bio's net margin of -49.30%. Fonar's return on equity of 4.12% beat TELA Bio's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TELA Bio	-49.30%	-1,320.81%	-55.83%
Fonar	6.35%	4.12%	3.07%

94.3% of TELA Bio shares are held by institutional investors. Comparatively, 50.6% of Fonar shares are held by institutional investors. 5.1% of TELA Bio shares are held by company insiders. Comparatively, 7.9% of Fonar shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

TELA Bio has a beta of 1.33, indicating that its stock price is 33% more volatile than the broader market. Comparatively, Fonar has a beta of 0.95, indicating that its stock price is 5% less volatile than the broader market.

In the previous week, TELA Bio had 1 more articles in the media than Fonar. MarketBeat recorded 2 mentions for TELA Bio and 1 mentions for Fonar. TELA Bio's average media sentiment score of 1.44 beat Fonar's score of 0.00 indicating that TELA Bio is being referred to more favorably in the media.

Company	Overall Sentiment
TELA Bio	Positive
Fonar	Neutral

TELA Bio presently has a consensus target price of $2.20, suggesting a potential upside of 211.79%. Given TELA Bio's stronger consensus rating and higher possible upside, equities analysts clearly believe TELA Bio is more favorable than Fonar.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TELA Bio	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Fonar	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Fonar beats TELA Bio on 9 of the 16 factors compared between the two stocks.

Get TELA Bio News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TELA vs. The Competition

Export

Metric	TELA Bio	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$33.13M	$3.55B	$6.70B	$12.22B
Dividend Yield	N/A	2.25%	2.67%	6.12%
P/E Ratio	-0.89	21.56	25.76	24.17
Price / Sales	0.39	337.05	559.40	100.03
Price / Cash	N/A	137.38	46.99	54.37
Price / Book	4.41	8.34	10.77	6.35
Net Income	-$38.83M	$23.91M	$3.57B	$337.63M
7 Day Performance	-11.91%	3.38%	2.15%	0.06%
1 Month Performance	-18.80%	1.51%	1.06%	-0.15%
1 Year Performance	-64.18%	65.14%	34.16%	27.55%

TELA Bio Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TELA TELA Bio	3.6083 of 5 stars	$0.71 -4.6%	$2.20 +211.8%	-61.9%	$33.13M	$80.81M	N/A	120	Positive News Short Interest Decrease Gap Down High Trading Volume
CVRX CVRx	3.0393 of 5 stars	$5.09 +4.8%	$11.50 +125.8%	-0.2%	$135.35M	$56.65M	N/A	160	News Coverage Analyst Upgrade
GUTS Fractyl Health	4.4249 of 5 stars	$0.84 -3.3%	$5.40 +542.9%	-57.3%	$133.74M	N/A	N/A	102	Positive News Gap Down
MBOT Microbot Medical	2.3803 of 5 stars	$1.82 -1.9%	$6.63 +265.0%	-28.7%	$121.91M	N/A	N/A	20	Gap Down
RCEL Avita Medical	3.7502 of 5 stars	$3.94 -2.2%	$7.25 +84.0%	-22.5%	$118.49M	$72.35M	N/A	130	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TELA) was last updated on 6/27/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

TELA Bio (TELA) Competitors

TELA vs. CVRX, GUTS, MBOT, RCEL, and FONR

How does TELA Bio compare to CVRx?

Summary

How does TELA Bio compare to Fractyl Health?

Summary

How does TELA Bio compare to Microbot Medical?

Summary

How does TELA Bio compare to Avita Medical?

Summary

How does TELA Bio compare to Fonar?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TELA vs. The Competition

TELA Bio Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

TELA Bio (TELA) Competitors

TELA vs. CVRX, GUTS, MBOT, RCEL, and FONR

How does TELA Bio compare to CVRx?

Do insiders and institutionals have more ownership in TELA or CVRX?

Which has more volatility & risk, TELA or CVRX?

Which has higher earnings & valuation, TELA or CVRX?

Does the media refer more to TELA or CVRX?

Is TELA or CVRX more profitable?

Do analysts rate TELA or CVRX?

Summary

How does TELA Bio compare to Fractyl Health?

Is GUTS or TELA more profitable?

Do analysts recommend GUTS or TELA?

Do institutionals and insiders hold more shares of GUTS or TELA?

Which has higher valuation and earnings, GUTS or TELA?

Does the media favor GUTS or TELA?

Which has more risk & volatility, GUTS or TELA?

Summary

How does TELA Bio compare to Microbot Medical?

Which has higher valuation and earnings, MBOT or TELA?

Do institutionals & insiders have more ownership in MBOT or TELA?

Does the media prefer MBOT or TELA?

Do analysts rate MBOT or TELA?

Which has more risk and volatility, MBOT or TELA?

Is MBOT or TELA more profitable?

Summary

How does TELA Bio compare to Avita Medical?

Which has more volatility & risk, RCEL or TELA?

Which has preferable valuation and earnings, RCEL or TELA?

Does the media refer more to RCEL or TELA?

Do analysts rate RCEL or TELA?

Do institutionals and insiders have more ownership in RCEL or TELA?

Is RCEL or TELA more profitable?

Summary

How does TELA Bio compare to Fonar?

Which has preferable valuation & earnings, TELA or FONR?

Is TELA or FONR more profitable?

Do institutionals and insiders hold more shares of TELA or FONR?

Which has more volatility and risk, TELA or FONR?

Does the media favor TELA or FONR?

Do analysts recommend TELA or FONR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TELA vs. The Competition

TELA Bio Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools